Catalase Gene Polymorphism in Patient with Diabetes Disease Type 1 in Karbala City

Authors

  • Abdulridha Mohammed Al-Asady1, Farah A. Al-marzook2 ,Thoalffakar A. ALhamed1

DOI:

https://doi.org/10.37506/mlu.v20i1.501

Abstract

Diabetes Mellitus (DM) is a collection of metabolic diseases categorized by hyperglycemia caused by insulin excretion deficiencies, insulin performance, or both DM are categorized into distinct kinds. Type 1 diabetes (T1D) is defined by breakdown of ?-cells, generally resulting in complete insulin deficiency. Type 2 diabetes (T2D) is a consequence of peripheral tissue insulin resistance. a complete of fifty patients and fifty control subjects were collected between February to October 2018. The genotyping of catalase were attained consuming polymerase chain reaction (PCR) in addition to restriction fragment length polymorphism (RFLP). We tend to firm vigorous changes within the genotype occurrences of catalase between patients with diabetes and controls using the P=0.038, OR =0.58 (0.48-0.78).

Author Biography

  • Abdulridha Mohammed Al-Asady1, Farah A. Al-marzook2 ,Thoalffakar A. ALhamed1

    1 Assist.Lecturer, College of Nursing, University of Warith Al-anbiya’a , Iraq, 2 Lecturer, College of Nursing, University of Warith Al-anbiya’a , Iraq

Downloads

Published

2020-04-09

How to Cite

Catalase Gene Polymorphism in Patient with Diabetes Disease Type 1 in Karbala City. (2020). Medico Legal Update, 20(1), 996-1001. https://doi.org/10.37506/mlu.v20i1.501